MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 27, 2007; DOI: 10.1124/mol.107.042655


This Article
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow All Versions of this Article:
mol.107.042655v1
73/4/1195    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.-B.
Right arrow Articles by Xu, T.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.-B.
Right arrow Articles by Xu, T.-L.


Received for publication October 12, 2007.
Revised December 22, 2007.
Accepted for publication December 27, 2007.

Alpha 2 Subunit Specificity of Cyclothiazide Inhibition on Glycine Receptors

Xiao-Bing Zhang 1, Guang-Chun Sun 2, Lu-Ying Liu 2, Fang Yu 2, Tian-Le Xu 2*

1 University of Science and Technology of China 2 Institute of Neuroscience and State Key Laboratory of Neuroscience

* Address correspondence to: E-mail: tlxu{at}ion.ac.cn

Abstract

In the mammalian cortex {alpha}2 subunit-containing glycine receptors (GlyRs) mediate tonic inhibition, but the precise functional role of this form of GlyRs is difficult to establish because of the lack of subtype-selective antagonist. In this study, we found that cyclothiazide (CTZ), an epilepitogenic agent, potently inhibited GlyR-mediated current (IGly) in cultured rat hippocampal neurons. The inhibition was glycine concentration-dependent, suggesting a competitive mechanism. Notably, when heterologously expressed in HEK293T cells, GlyRs containing the {alpha}2 but not {alpha}1 or {alpha}3 subunit were inhibited by CTZ, indicating subunit specificity of CTZ action. In addition, the degree of CTZ inhibition on IGly in rat spinal neurons declined with time in culture, in parallel with a decline of {alpha}2 subunit expression, which is known to occur during spinal cord development. Furthermore, site-directed mutagenesis indicates that a single amino acid threonine at position 59 near the N-terminal of the {alpha}2 subunit confers the specificity of CTZ action. Thus CTZ is a potent and selective inhibitor of {alpha}2-GlyRs, and threonine 59 site plays a critical role in the susceptibility of GlyR to CTZ inhibition.


Key words: Glycine, Ion channel regulation, Mutagenesis/Chimeric approaches





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics